Zevra Therapeutics, Inc.
USD10.96
+0.08 (+0.74%)
CEO
Neil F. McFarlane
IPO Date
2015-04-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$11.03
Prev. Close
$10.88
Day Low
$10.87
Day High
$11.10
52W Low
$7.16
52W High
$13.16
Market Cap
$0.65B
Volume
1.42M
| 20,000 |
| $0.00 |
| 13 May 2026 | Thompson Rahsaan | Chief Legal & Compliance | S-Sale | Disposed | 1,794 | $11.30 |
| 26 Mar 2026 | Bode John B | director | M-Exempt | Acquired | 39,200 | $4.97 |
| 26 Mar 2026 | Bode John B | director | M-Exempt | Acquired | 39,200 | $4.89 |
| 26 Mar 2026 | Bode John B | director | M-Exempt | Disposed | 39,200 | $4.97 |
| 26 Mar 2026 | Bode John B | director | M-Exempt | Disposed | 39,200 | $4.89 |
| 19 Mar 2026 | Renz Justin A | CFO | A-Award | Acquired | 300,000 | $9.55 |
| 19 Mar 2026 | Renz Justin A | officer | Disposed | 0 | $0.00 |
| 10 Feb 2026 | McFarlane Neil F. | director, officer: President and CEO | M-Exempt | Disposed | 37,500 | $0.00 |